GLP-1 Medications for Weight Loss: Semaglutide, Tirzepatide, and Retatrutide Compared The landscape of obesity treatment has shifted dramatically over the past decade, thanks to a class of medications known as GLP-1 receptor agonists
These unlawful marketing and sales practices, including the use of Novo Nordisk trademarks in connection with these practices, have created a high risk of consumer confusion and deception as well as potential safety concerns, the release continues
Weeks 1 to 4: Early Adjustment Phase Weeks 1 to 4 are often about learning how your body responds
Time will tell if the promise is real
Our medical weight loss programs may be right for you if you have struggled to lose weight or maintain weight loss despite diet and exercise efforts, have a BMI in the overweight or obese range (BMI 27 with weight-related health conditions, or BMI 30), have weight-related health conditions such as prediabetes, type 2 diabetes, hypertension, high cholesterol, sleep apnea, or joint pain that would benefit from weight reduction, are seeking a medically supervised, evidence-based program with professional support rather than a fad diet or crash approach, or want a sustainable long-term strategy for weight management rather than a temporary quick fix
